AMANDA BLEVINS: Open Payments
NPI 1215301643 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$667 in 34 payments from 13 companies in 2025. Trend: 2023 $561 · 2024 $710 · 2025 $667
Food & beverage: $667
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $167 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| Lilly USA, LLC | 3 | $55 |
| ABBVIE INC. | 3 | $54 |
| Astellas Pharma US Inc | 2 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| PFIZER INC. | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
Products named: Wegovy, REXULTI, Ozempic, CAPLYTA, VRAYLAR, Veozah, TRINTELLIX, MOUNJARO.
Industry payments across TN — which companies pay providers there.
